Neurogenic monkey brains

Written byKerry Grens

| 1 min read

Last week the Journal of Neuroscience published linkurl:findings;https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=17475797&query_hl=9&itool=pubmed_docsum suggesting antidepressant treatment stimulates neurogenesis in primates, something researchers had spotted in rodents and tree shrews previously. These results, which report neurogenesis in monkeys undergoing electroconvulsive shock (ECS), come close to confirming a hunch by linkurl:Brain Cells Inc,;https://www.braincellsinc.com/index.html a company I linkurl:profiled;https://www.the-scientist.com/2007/4/1/40/1 in the April issue of The Scientist. Brain Cells is currently banking millions on the idea that human antidepressant treatments work via neurogenesis. Indeed, two of the paper's co-authors are founders of Brain Cells Inc. The company's approach to finding new antidepressants is to screen drugs for neurogenic properties, and it is in the process of raising funds to take one such drug to clinical trials. But it's still preliminary. Monkey data don't always apply to humans, and it remains to be seen whether the ECS-induced neurogenesis in primates can also be induced by drugs. The other fundamental question is whether neurogenesis is sufficient for, or even related to, antidepressant effects. As the authors write, 'It is indeed possible that antidepressant-induced neurogenesis is an epiphenomenon unrelated to therapeutic effects.' Stay tuned as The Scientist tracks the story. L. Santarelli et al., 'Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants,' Science, 301:805-9, 2003. PMID:12907793 P.S. Erikkson et al., 'Neurogenesis in the adult human hippocampus,' Nature, 4:1313-7, 1998. PMID:9809557 J.E. Malberg et al., 'Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus,' The Journal of Neuroscience, 20:9104-10, 2000. PMID:11124987

Meet the Author

Kerry Grens

Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

View Full Profile